We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




‘Smart Patch’ Detects Alzheimer's Using Microneedle Technology

By LabMedica International staff writers
Posted on 19 Jan 2023
Print article
A new diagnostic tool uses skin as a window to the body and brain (Photo courtesy of Swansea University)
A new diagnostic tool uses skin as a window to the body and brain (Photo courtesy of Swansea University)

A new ‘smart patch’ can detect proinflammatory biomarkers of neurodegenerative diseases such as Parkinson's and Alzheimer's by using microneedle technology. The breakthrough in the advancement of transdermal capability could pave the way for the use of ‘smart patches’ to detect certain biomarkers within skin interstitial fluid (ISF) in a “bloodless” manner. The patches are comprised of arrays of tiny needles (microneedles) that are designed to break the skin barrier – in a minimally invasive manner - and monitor clinically significant biomarkers. They can be self-administered for POC diagnosis or at home. The innovation could prove to be a game changer in the field of early neurodegenerative disease detection.

The skin is the largest organ in the body and contains more ISF than the total volume of blood. The fluid is an ultrafiltrate of blood and holds biomarkers that complement other biofluids like sweat, saliva, and urine. It can be sampled in a minimally invasive way and used for testing at the POC as well as in real time using microneedle devices. Dr. Sanjiv Sharma, a leading scientist at Swansea University (Swansea, UK) who had previously developed the world’s first COVID-19 ‘smart patch’, employed microneedle array-based biosensing patches as wearable transdermal sensors to detect the proinflammatory cytokine IL-6. IL-6 is present in the skin ISF with other cytokines and is implicated in several clinical states including neurodegenerative diseases and fatal pneumonia due to SARS-CoV-2.

Dr. Sharma and his collaborators were able to detect IL-6 at concentrations as low as 1 pg/mL in synthetic skin ISF, suggesting its utility for routine POC, bloodless measurements in simpler settings, across the world. The devices developed by the team are scalable, and the resulting sensor has a short measurement time of six minutes, along with high accuracy and low limit of detection. The new diagnostic tool for screening of inflammatory biomarkers in POC testing tunes the skin into a window to the body and vital organs like the brain.

“Biomark ISEP Porto have pioneered applications of molecular imprinted polymers (MIPs) and extended them to different healthcare applications,” said Felismina Moreira from the School of Engineering, Polytechnic Institute, who also collaborated in the research. “Together with Swansea's expertise in transdermal diagnostics we have demonstrated that the MIPs together with the microneedle arrays offers a fantastic platform for the development of point of care devices for bloodless testing. These can be extended to diagnostics for cardiovascular, cancer and neurodegenerative disorders.”

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Calprotectin Assay
Fecal Calprotectin ELISA
New
Isothermal Amplification Technology
SIBA

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.